Guselkumab Efficacy after Withdrawal Is Associated with Suppression of Serum IL-23-Regulated IL-17 and IL-22 in Psoriasis: VOYAGE 2 Study - Concepedia

Concepedia

Publication | Open Access

Guselkumab Efficacy after Withdrawal Is Associated with Suppression of Serum IL-23-Regulated IL-17 and IL-22 in Psoriasis: VOYAGE 2 Study

DOI Full Paper Access

100

Citations

23

References

2019

Year

Kenneth B. Gordon, April W. Armstrong, Peter Foley, Michael Song, Yaung‐Kaung Shen, Shu Li, Ernesto J. Muñoz‐Elías, Patrick Branigan, Xuejun Liu, Kristian Reich

Journal of Investigative Dermatology

InflammationCytokineImmunologyVoyage 2Guselkumab EfficacyClinical DermatologyDermatologyExperimental DermatologyImmunotherapyMedicineInflammatory DiseaseSerum Il-23-regulated Il-17

References

	Year	Citations

Page 1

Page 1